miR-124-mediated temozolomide sensitivity and DNA repair modulation in Glioblastoma Multiforme

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Glioblastoma Multiforme (GBM) is an aggressive primary brain tumor.
• Current treatments, including temozolomide (TMZ), often face resistance.
• MicroRNA (miRNA)-targeted therapy combined with TMZ is a potential strategy to enhance treatment efficacy.

Purpose of the Study:

• To investigate the effect of miR-124 overexpression on TMZ resistance in GBM cell lines.
• To analyze the impact of miR-124 on genes involved in DNA repair and autophagy.
• To explore miR-124 as a potential therapeutic modulator for GBM.

Main Methods:

• Bioinformatics prediction of miR-124-3p target genes.
• Overexpression of miR-124 in U-87 and U-251 GBM cell lines using lentiviral transduction.
• MTT assay to assess TMZ sensitivity and qRT-PCR to quantify gene expression.

Main Results:

• Overexpression of miR-124 significantly increased TMZ sensitivity in U-87 GBM cells.
• mRNA levels of DNA repair genes (e.g., PRRX1, ETS, VIM, PTBP1) and autophagy genes (Beclin-1, Atg-5) were significantly reduced by miR-124.
• Bioinformatics analysis identified 60 potential target genes for miR-124-3p.

Conclusions:

• Modulating DNA repair pathways via miR-124 overexpression may enhance glioma cell chemosensitivity to TMZ.
• miR-124 potentially targets genes involved in DNA repair and autophagy, contributing to TMZ resistance.
• Further research is needed to confirm the role of autophagy in miR-124's anti-cancer activity.